Z-0847-2013 Class II Terminated

Recalled by Codman & Shurtleff, Inc. — Raynham, MA

FDA device recall Z-0847-2013 was initiated by Codman & Shurtleff, Inc. on Jan 11, 2013 and is designated Class II. Reason for recall: Sterility of device may be compromised due to lack of package integrity The recall status is terminated (terminated Aug 10, 2015). Affected quantity: 867 units.

Recall details

Product Type
Devices
Report Date
Feb 27, 2013
Initiation Date
Jan 11, 2013
Termination Date
Aug 10, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
867 units

Product description

NEUROPATH 6Fx100 GUIDING CATH MPD Product Code: GMD60900000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices

Reason for recall

Sterility of device may be compromised due to lack of package integrity

Distribution pattern

Worldwide Distribution - USA (nationwide) and Internationally to Austria, Belgium, Canada, Chile, Costa, Rica, Czech Republic, Denmark, France, Germany, Great Britian/UK, Ireland, Italy, Lithuania, Malaysia, Netherlands, New Zealand, Norway, Poland, Portugal, Singapore, Slovakia, Spain, and Switzerland.

Code information

All unexpired lots

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0847-2013
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Codman & Shurtleff, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-0847-2013. Report a data issue: hello@regdatalab.com.